US2020248264A1PendingUtilityA1

System and method for cleaning noisy genetic data and determining chromosome copy number

Assignee: NATERA INCPriority: Jul 29, 2005Filed: Apr 8, 2020Published: Aug 6, 2020
Est. expiryJul 29, 2025(expired)· nominal 20-yr term from priority
C12Q 1/6869C12Q 1/6806C12Q 2545/114C12Q 2537/149C12Q 1/6827G16B 20/10G16B 40/00G16B 20/00G16B 30/00C12Q 2600/118C12Q 2600/156C12Q 1/6883G16B 25/00C12Q 1/6876C12Q 2600/158C12Q 1/6855C12Q 1/6886
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein is a system and method for increasing the fidelity of measured genetic data, for making allele calls, and for determining the state of aneuploidy, in one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available. Poorly or incorrectly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related individuals. In accordance with one embodiment, incomplete genetic data from an embryonic cell are reconstructed at a plurality of loci using the more complete genetic data from a larger sample of diploid cells from one or both parents, with or without haploid genetic data from one or both parents. In another embodiment, the chromosome copy number can be determined from the measured genetic data, with or without genetic information from one or both parents.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for measuring an amount of DNA from a first individual in a blood sample of a second individual, comprising:
 isolating cell-free DNA from the blood sample which comprises DNA from the first individual and DNA from the second individual;   performing targeted amplification using target-specific primers to amplify a plurality of loci of interest on the isolated and further performing a universal amplification after the targeted amplification;   performing sequencing-by-synthesis that comprises clonal amplification and measurement of sequences of the clonally amplified DNA; and determining the amount of the DNA from the first individual in the blood sample.   
     
     
         2 . The method of  claim 1 , wherein the loci of interest are SNP loci. 
     
     
         3 . The method of  claim 1 , wherein the loci of interest are on a plurality of chromosomes. 
     
     
         4 . The method of  claim 1 , wherein the clonally amplified DNA comprises clonally amplified DNA from the first individual and clonally amplified DNA from the second individual. 
     
     
         5 . The method of  claim 4 , wherein sequences of the clonally amplified DNA from the first individual are measured along with sequences of the clonally amplified DNA from the second individual.

Join the waitlist — get patent alerts

Track US2020248264A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.